Tracy R P. Inflammation in cardiovascular disease [J]. Circulation, 1998.2000.
|
Inoue N. Vascular C-reactive protein in the pathogenesis of coronary artery disease:role of vascular inflammation and oxidative stress [J]. Cardiovasc Hematol Disord Drug Targets, 2006(4):227.
|
Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes [J]. American Journal of Cardiology, 2001.10k.
|
Pietila K O, Harmoinen A P, Jokiniitty J J. Serum Creactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of followup in patients under thrombolytic treatment [J]. European Heart Journal, 1999.1345.
|
Torres J L, Ridker P M. Clinical use of high-sensitivity C-reactive protein for the prediction of adverse cardiovascular events [J]. Current Opinion in Cardiology, 2003(6):471.
|
Ridker P M, Cushman M, Stampfer M J, Tracy R P Hennekens C H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J]. New England Journal of Medicine, 1997.973.
|
Ridker P M, Buring J E, Shih J, Matias M Hennekens C H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women [J]. Circulation, 1998.731.
|
Taniguchi H, Momiyama Y, Ohmori R, Yonemura A Yamashita T Tamai S. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease [J]. Atheroclerosis, 2005.173.
|
Azar R.R, Aoun G, Fram D B. Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests [J]. American Journal of Cardiology, 2000.205.
|
Aziz N, Fahey J L, Detels R. Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood [J]. Clinical and Diagnostic Laboratory Immunology, 2003.652.
|
Zeltser D, Rogowski O, Mardi T. Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive Cre active protein [J]. Atheroclerosis, 2004(2):297.
|
Meuwissen M, van der Wal A C, Niessen H W, Koch K T, de Winter R J. Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction [J]. Journal of Clinical Pathology, 2006(2):196.
|
Videm V, Wiseth R, Gunnes S, Madsen H O, Garred P. Multiple inflammatory markers in patients with significant coronary artery disease [J]. International Journal of Cardiology, 2007(1):81.
|
Memon L, Spasojevic-Kalimanovska V, Boqavac-Stanojevic N. Association of C-reactive Protein With The Presence and Extent of Angiographically Verified Coronary Artery Disease [J]. Tohoku Journal of Experimental Medicine, 2006.197.
|